Introduction and hypothesis The aim of this study is to estimate efficacy and safety of mesh in surgery for uterine or vault prolapse. Methods Seventeen electronic databases were searched for relevant studies that were published from 1980 onwards. Results Fifty-four studies involving 7,054 women were included. For sacrocolpopexy (average follow-up 23 months), the risk of clinical recurrence ranged from 0% to 6%, persistent symptoms ranged from 3% to 31% and mesh erosion from 0% to 12%. For infracoccygeal sacropexy (average follow-up 13 months), the risk of clinical recurrence ranged from 0% to 25%, persistent symptoms from 2% to 21% and mesh erosion 0% to 21%. Limited evidence was available for sacrocolpoperineopexy and uterine suspension sling to draw reliable estimates. Conclusions Sacrocolpopexy was associated with a low risk of recurrence but with a relatively high risk of mesh erosion. Ranges of estimates for outcomes for other mesh techniques were wide.
Introduction
Prolapse of the uterus or vaginal vault (middle compartment) affects a woman's health by its local physical effects (pressure, bulging, heaviness or discomfort) or its effect on urinary, bowel or sexual function. Current treatment options for uterine or vault prolapse include pelvic floor muscle training [1] , use of pessaries (mechanical devices such as rings or shelves) [2] and surgery [3] .
Prolapse surgery not involving mesh includes hysterectomy, cervical amputation and uterine/vault attachment with sutures to the pelvic ligaments. Surgical techniques using mesh include sacrocolpopexy, sacrocolpoperineopexy, infracoccygeal sacropexy (also known as posterior intravaginal slingplasty (IVS)) and uterine suspension sling.
In sacrocolpopexy, the vaginal vault is attached with a mesh bridge to the periosteum of the sacral promontory. If this is carried out at the same time as hysterectomy, the aim of the sacrocolpopexy is prophylaxis to prevent future vault prolapse. Sacrocolpoperineopexy is a variation of sacrocolpopexy where extra mesh is inserted between the posterior vaginal wall and the rectum down to the perineum. Use of sacrocolpoperineopexy is contentious, because the relatively large amount of mesh may increase risks of mesh erosion. In infracoccygeal sacropexy, the uterus or vault is suspended using a mesh tape with the aid of a trochar (tunnelling device) through each of the ischiorectal fossae. The uterine suspension sling technique can only be used in women who wish to conserve their uterus, i.e. for uterine prolapse repair. In this procedure, the uterus is attached with mesh to pelvic ligaments or to the periosteum of the sacral promontory.
Both the efficacy and safety of mesh in surgery for uterine or vault prolapse are uncertain. This report presents the estimated efficacy and safety of mesh in surgery for uterine or vault prolapse. It is based on a review that was commissioned through the UK National Institute for Health and Clinical Excellence (NICE) Interventional Procedures Programme. An electronic version of the full report is available from the NICE website [4] .
Methods

Search strategy
We searched electronic databases, conference proceedings and relevant websites, contacted 11 manufacturers and scrutinised bibliographies of retrieved papers to identify reports of published and ongoing studies on the efficacy and safety of mesh in surgery for uterine or vault prolapse repair. Searches, designed to be highly sensitive and using both controlled vocabulary and free-text terms, were restricted to publications from 1980 onwards and, for conference proceedings, to randomised controlled trials published from 2005 onwards. RCTs published solely as conference abstracts prior to 2005 were not searched for as it was assumed that they were likely to be published within 3 years as a full-text article. The review was restricted to English language studies due to the complexity of the terminology in this topic area. Studies that reported only procedures without mesh were not identified separately. Full details of the search strategies used are reproduced in the original report [4] 
Inclusion and exclusion criteria
One reviewer screened titles/abstracts. Any uncertainties were discussed with a second reviewer, and a consensus was reached. Full-text copies of all reports deemed to be potentially relevant were obtained and assessed by the main reviewer for inclusion.
Full-text RCTs, RCTs published as conference abstracts from 2005 onwards, non-randomised comparative studies and case series using mesh were sought. As the volume of literature for sacrocolpopexy was substantial, only case series with a sample size of at least 100 women were included. There was no sample size restriction placed on case series that reported other mesh techniques, because the volume of literature for these techniques was very limited.
Case series with a mean follow-up of at least 1 year were included for both efficacy and safety. Case series with a mean follow-up of less than 1 year were included for safety outcomes only. We considered 1 year to be a minimum adequate period of time in which to assess the efficacy of prolapse repair.
The participants were women undergoing uterine or vault prolapse surgery. Studies of women with cancer or with prolapse caused by congenital anomalies, inherited conditions or creation of a neovagina were excluded. Studies with women undergoing other concomitant operations, such as anterior or posterior vaginal wall prolapse repair or anti-incontinence procedures, were included providing that the main indication for surgery was uterine or vault prolapse.
We considered all surgical techniques for uterine or vault prolapse repair, which involved the use of mesh. There were no restrictions on the type of mesh used. For RCTs and non-randomised comparative studies, the comparators were any other surgical techniques with or without mesh.
The primary outcomes for efficacy were patient-reported persistent prolapse symptoms and clinician-reported recurrence of prolapse at the original site measured with a validated quantitative tool, e.g. the Pelvic Organ ProlapseQuantification system (14 included studies used this tool) or Baden-Walker system (five included studies used this tool). Secondary outcomes for efficacy included new (de novo) prolapse at other sites that were free of prolapse before surgery, the need for repeat surgery for prolapse (both recurrent at the same site and de novo), persistent urinary symptoms, persistent bowel symptoms and persistent sexual symptoms. For urinary, bowel and sexual symptoms, only women who reported these symptoms at baseline were counted. If possible, only women who were sexually active were considered for sexual function outcomes.
The primary outcome for safety was mesh erosion. Secondary outcomes included blood loss; damage to surrounding organs during the operation; an operation for mesh erosion or removal; new urinary, bowel or sexual symptoms; and infection. For new urinary, bowel or sexual symptoms, only women who were free of these symptoms at baseline were considered for these outcomes.
We also considered other serious and minor adverse effects not otherwise specified, operation time and hospital stay. Details on these outcomes are provided in the full report [4] .
Data extraction and quality assessment Data extraction and methodological quality assessment of the RCTs were conducted by two reviewers (XJ and CG) independently. The main reviewer (XJ) extracted data and assessed the quality of the remaining studies (due to resource constraints imposed by the review timelines). Two separate quality assessment checklists were used according to study design. Both checklists were developed by the Review Body for Interventional Procedures (ReBIP; Health Services Research Units at the Universities of Aberdeen and Sheffield) an independent review body that carries out systematic reviews for NICE's Interventional Procedures Programme. The checklists were adapted from several sources [5] [6] [7] .
Data analysis
Four techniques that use mesh were identified: sacrocolpopexy, sacrocolpoperineopexy, infracoccygeal sacropexy and uterine suspension sling. Data analyses were conducted separately for each of the technique, and for each technique, data were presented separately for three subgroups of women according to the type of prolapse being repaired: uterine prolapse, vault prolapse and uterine and/or vault prolapse (where the data were not reported separately).
Meta-analyses were conducted of full-text RCTs, RCTs available as conference abstracts and non-randomised comparative studies (using Cochrane Collaboration Review Manager, RevMan 4.3 software). These allowed the efficacy and safety of procedures using mesh versus procedures without mesh and between different techniques that used mesh, to be compared directly. All tests of significance were performed at the 5% level. For each outcome, the median and the range of the event rates were calculated by study design (RCTs, non-randomised comparative studies and case series/registries). This required each arm of an RCT or comparative study to be considered as a separate case series.
Pre-specified subgroup analyses were planned for different surgical approaches (vaginal, open abdominal and laparoscopic), different mesh types (non-absorbable synthetic mesh, absorbable synthetic mesh, biological absorbable graft and combined mesh containing both absorbable and non-absorbable material) and for women having primary versus secondary repairs.
Results
Number and type and quality of included studies From the initial 853 publications identified by the search strategy, 54 studies (reported in 60 publications) were included, of which five were full-text RCTs [8] [9] [10] [11] [12] , three were RCTs available as conference abstracts [13] [14] [15] , 17 were non-randomised comparative studies [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] and 29 were case series . Seven manufacturers provided relevant studies, all of which had already been identified by our searches. The screening process is summarised in Fig. 1 . Appendix (Tables 6, 7, 8, 9) show details of study design, methods, participants and interventions for sacrocolpopexy, sacrocolpoperineopexy, infracoccygeal sacropexy and uterine suspension sling. Two studies involving 238 women reported a mixture of above techniques but did not report them separately [20, 40] . Details and results of these two studies are available in the full report [4] . Seven ongoing RCTs [62] [63] [64] [65] [66] [67] [68] and one ongoing case series [66] were also identified.
The included studies took place during the period 1991-2007 in 16 countries. Overall, 7,054 women were treated in total, of whom 4,456 were treated with sacrocolpopexy, 282 with sacrocolpoperineopexy, 976 with infracoccygeal sacropexy, 159 with uterine suspension sling, 238 a mixture of the above mesh techniques and 943 with no-mesh techniques.
Across studies, the average age of the women was 61 years. Women who were treated with uterine suspension sling (a technique allows uterus to be preserved for future pregnancy) were younger (average age 37 years) than those treated with other techniques (average age around 65 years). Only six studies provided information on whether the procedures were primary or secondary, of which two presented data on primary surgery alone.
A laparoscopic approach can be used to perform sacrocolpopexy, sacrocolpoperneopexy or uterine suspension sling (infracoccygeal sacropexy uses a vaginal approach). Five included studies reported that all the operations were done laparoscopically and were all for sacrocolpopexy (7.5%, 333/ 4,456) [25, 26, 29, 32, 46] . The remaining studies used open procedures, a mixture of open and laparoscopic procedures, or did not report the surgical technique used.
We assessed the methodological quality of the full-text studies only because the abstracts only provided limited information about quality. The study quality of RCTs, nonrandomised comparative studies and case series is summarised in Figs. S1, S2 and S3, respectively (supplementary data).
Sacrocolpopexy
Thirty-two studies (four full-text RCTs [8] [9] [10] [11] , one RCT available as conference abstract [13] , 15 non-randomised comparative studies [16-19, 21-26, 28-32] and 12 case series with sample sizes over 100) involving a total of 4,456 women provided data on sacrocolpopexy. Two studies [13, 19] reported on uterine prolapse (hysterectomy followed by sacrocolpopexy in the same procedure), seven studies reported vault prolapse (sacrocolpopexy alone) [9, 11, 21, 26, 29, 42, 47] , two studies reported uterine and vault prolapse separately [23, 61] and 21 studies [8, 10, 16-18, 22, 24, 25, 28, 30-32, 35-39, 46, 51, 57, 59] reported data from women having uterine and/or vault prolapse together (Appendix, Table 6 ). Mesh types varied across studies. The median (range) of mean follow-up across these 32 studies was 23 months (8 to 66 months). Table 1 shows, for each type of study, the medians and ranges of event rates across studies for primary outcomes for sacrocolpopexy.
Efficacy
Four RCTs reported the efficacy of sacrocolpopexy. One small RCT involving 89 women with vault prolapse compared sacrocolpopexy (mesh) with sacrospinous colpopexy (no mesh): differences in risk of persistent symptom (RR 0.70, 95% CI 0.17 to 2.95) and risk of prolapse recurrence (RR 0.23, 95% CI 0.05 to 1.04) were not statistically significant [11] . Another RCT also involving 89 women with vault prolapse compared two different types of mesh (polypropylene versus fascial lata). No woman had prolapse recurrence 1 year after treatment (0/45 versus 0/44) [9] . The RCT available as a conference abstract reported on 47 women with uterine prolapse. No woman (0/23) had prolapse recurrence after treatment of hysterectomy followed by sacrocolpopexy (mesh) compared with one woman (1/24) after treatment of vaginal hysterectomy (no mesh) [13] . The fourth RCT involved 80 women. The types of prolapse that the women had (uterine, vault or a mixture of both) were not reported. There were no statistically significant differences in the risks of persistent symptoms between sacrocolpopexy (mesh) and sacrospinous colpopexy (no mesh) (RR 5.51, 95% CI 0.27 to 111.31) [8] .
Meta-analysis of these four RCTs could not be conducted because of the heterogeneity in terms of the types of prolapse, comparator used and outcomes reported.
The risks of recurrence across all study designs ranged from 0% to 6% in 14 studies involving 1,054 women (median 1.2%, Table 1 ), while the risks for persistent prolapse symptoms ranged from 3% to 31% in nine studies involving 638 women (median 22%). In four studies involving 451 women, risks of needing a further operation for recurrent or de novo prolapse ranged from 0% to 14% (median 8%). Estimates for other outcomes were based on single studies only.
Safety
The risk of mesh erosion ranged from 0% to 12% (median 5.4%, 27 studies, n=2,922, Table 1 ). Zero to 11% of women required an operation for mesh erosion (median 3.8%, 17 studies, n=2,074). In studies reporting mesh erosion, most studies used non-absorbable synthetic mesh ( Table 2 ). The median mesh erosion rates across studies were 4.0% (range 0% to 12.0%, 21 studies, n=1,869) for non-absorbable synthetic mesh compared with 0% (range 0% to 0.8%, five studies, n=229) for absorbable biological graft. No studies reported mesh erosion data for absorbable synthetic mesh, and only one study reported mesh erosion for combined mesh (4.3%, 1/23).
For other safety outcomes, the proportion of women who required a blood transfusion for sacrocolpopexy ranged from 0% to 17% (median 1.7%, 19 studies, n=2,080). The range for women suffering organ damage varied from 0% to 8% (median 2.1%, 15 studies, n=1,723). New urinary symptoms in women who did not have these symptoms at baseline occurred in 4% to 9% (median 6.8%, four studies, n=294).
The estimate for new bowel symptoms (1%, 2/178) was based on a single study, and the estimate for new sexual symptoms (range 9% to 15%, n=87) was based on two small studies. The range for infection was wide, which reflected the variety of ways used to define it (0.8% to 68%, 17 studies, n=1,391). Data were available for meta-analysis comparing blood transfusion, damage to surrounding organs, infection and new urinary symptoms between sacrocolpopexy (mesh) and sacrospinous colpopexy (no mesh). There was not enough evidence to demonstrate a difference in any of these outcomes between the operations [4] .
Sacrocolpoperineopexy
Two studies involving 442 women reported on sacrocolpoperineopexy [31, 58] (Appendix, Table 7 ). Table 3 shows the event rates for primary outcomes for sacrocolpoperineopexy. Neither of the two studies gave details of uterine and vault prolapse separately. Risks of mesh erosion reported by these two studies were similar (8.5% in 118 women in 6 months and 8.3% in 169 women in 14 months).
Infracoccygeal sacropexy (posterior IVS)
Fourteen studies (two RCTs available as conference abstracts [14, 15] , one non-randomised comparative study [27] , two case series with sample sizes ≥100 [45, 60] and nine case series with sample sizes <100 [41, 43, 44, 48, [52] [53] [54] [55] [56] ) involving 976 women provided data on infracoccygeal sacropexy. One study [27] reported uterine repair (uterus conserved), five [14, 41, 43, 44, 53] reported vault repair, one reported uterine and vault repairs separately [56] and seven [15, 45, 48, 52, 54, 55, 60] studies reported uterine and vault repairs together (Appendix, Table 8 ). The median follow-up across these 14 studies was 13 months (range 5 to 30 months). The ranges of event rates for primary outcomes are shown in Table 4 . Meta-analysis was not possible, because the comparative studies used different comparators.
Efficacy
The proportion of women with persistent prolapse symptoms ranged from 2% to 21% (median 8.8%, n=262, three studies) after infracoccygeal sacropexy, whereas the range for prolapsed recurrence was 0% to 25% (median 4.8%, 9 studies, n=402). In three studies (n=288), the re-operation rate varied from none to 30% (median 7.9%). Estimates for other outcomes were based on single studies with few women.
Safety
The risks of mesh erosion ranged from 0% to 21% (median 6.7%, 11 studies, n=889), and 0.3% to 17% of women needed an operation for mesh erosion (median 7.2%, six studies, n=678). All studies reporting mesh erosion used non-absorbable synthetic mesh. The need for blood transfusion ranged from 0% to 2% (seven studies, n= 383). The risks of organ damage ranged from 0% to 2.7% (median 0%, nine studies, n=684). Little evidence was available for new urinary symptoms, bowel symptoms and sexual symptoms in women who did not have these symptoms at baseline. Infection ranged from 0% to 9% (eight studies, n=698).
Uterine suspension sling
Six studies [12, 19, 33, 34, 49, 50] involving 239 women reported on uterine suspension sling operations. One was a full-text RCT [12] , one was a non-randomised comparative study [19] and four were case series [33, 34, 49, 50] (Appendix, Table 9 ). All of the case series had a sample size of less than 100. Five of the six studies reported sacrohysteropexy (uterus suspended to the sacrum with a mesh bridge), and the other [49] reported a different technique (suspending the uterus to the pectineal ligaments). The median follow-up across the six studies was 33 months (12 to 95 months). Meta-analysis was not possible, because the comparative studies used different comparators.
Efficacy, safety, operation time and hospital stay Table 5 shows the event rates for primary outcomes. The range of persistent prolapse symptoms was wide (0% to 39%, median 3.3%, three studies, n=91). The risks of recurrence ranged from 0% to 8% (median 3.3%, five studies, n=136), while the risks of requiring a re-operation for prolapse ranged from 0% to 22% (median 3.3%, three studies, n=107). Little evidence was available for estimating other efficacy outcomes or any of the safety outcomes.
The study in which the uterus was suspended to the pectineal ligaments reported outcomes on persistent prolapse symptoms (0/20) and blood loss (0/20) [49] .
Discussion
Summary of the evidence
The review indicated that although sacrocolpopexy is associated with an apparent risk of clinical recurrence ranging from 0% to 6% (at an average follow-up of 2 years), the incidence of persistent prolapse symptoms (range 3% to 31%) and need for a further prolapse a Results from the two arms of one study were combined operation (range 2% to 25%) were relatively high. There were risks from adverse effects such as mesh erosion (range 0% to 12%), which often required a further operation for mesh erosion (range 1% to 11%). Non-absorbable mesh was associated with a higher risk of mesh erosion (median 4.0%, range 0% to 12.0%) compared with absorbable biological graft (median 0%, range 0% to 0.8%). Sacrocolpoperineopexy was associated with 8% of mesh erosion at an average follow-up of 1 year. Little evidence was available for other outcomes.
For infracoccygeal sacropexy, persistent symptoms ranged from 2% to 21% at an average follow-up of 1 year, clinical recurrence varied from 0% to 25%, mesh erosion from 0% to 21% and operation for mesh erosion from 2% to 17%.
For uterine suspension sling, the clinical recurrence rates ranged from 0% to 8% at an average follow-up of 3 years, whereas persistent symptoms ranged from 0% to 39%. However, little evidence was available for safety outcomes.
Assumptions, limitations and uncertainties
In terms of the methodological quality of the included studies, in three of the five full-text RCTs, allocation was adequately concealed. Four of these studies reported loss to follow-up (range 5% to 15%). Only three of the 17 non-randomised comparative studies collected data prospectively. Five of these studies reported loss to followup (range 4% to 55%). Ten of the 29 case series collected data prospectively. Twelve case series reported loss to follow-up (range 2% to 74%). Data were extracted as reported.
We aimed to review separately data from women having uterine prolapse and vault prolapse, because the operations, and hence the efficacy and safety, might be different in these two populations. However, the majority of the studies (32/54) reported data from women having uterine or vault repairs without separating the groups. As there was limited evidence for uterine prolapse repair and for vault prolapse repair alone, we did review evidence from studies that reported a mixture of uterine and vault prolapse.
We did not separate data by surgical approach. We are aware that the laparoscopic approach is gaining in popularity. This could be applied in sacrocolpopexy, sacrocolpoperineopexy or uterine suspension sling. A small proportion of the included studies reported that the operations were done laparoscopically and were all for sacrocolpopexy (7.5%, 336/4,456) [25, 26, 29, 32, 46] . It is important to determine whether safety and efficacy of mesh differ in women having primary versus recurrent prolapse repairs. However, of the 54 included studies, only two case series [35, 61] reported exclusively on women having primary repairs. Another four studies [18, 34, 49, 51] reported the case mix of primary and secondary operations but did not report outcome data separately for the two groups. It is likely that the remaining 48 studies included women having both primary and secondary surgery, but this was not reported.
There was a very limited number of RCTs available (20%, 11/54) of which five were available only as conference abstracts. The number of RCTs in each subgroup (by two types of prolapse and by four different surgical techniques) was even smaller (Appendix, Tables 6, 7, 8, 9) . Data were therefore too few to compare efficacy and safety between surgical techniques using mesh (each type) and no mesh and between different mesh techniques.
We pragmatically considered 1 year as an adequate minimum period of time to assess the efficacy of middle compartment prolapse repair. However, as the mean time to re-operation is 12 years [69] , 1 year may be too short to judge success. Therefore, failure rates at 1 year may not be representative of longer-term efficacy. Prospective studies will require extended follow-up to assess meaningful mesh failure rates.
Nevertheless, the results were considered generalisable as the majority of studies recruited participants from a spectrum of routine practice, without restrictions for the severity of prolapse or other patient characteristics.
Conclusions and implications
In general, sacrocolpopexy was associated with a low risk of recurrence, but the risks of persistent prolapse symptoms, re-operation and mesh erosion were relatively high. The estimates for the efficacy and safety outcomes for infracoccygeal sacropexy were wide. There was only limited evidence for efficacy and safety for sacrocolpoperineopexy or uterine suspension sling.
In consequence, in January 2009, NICE (UK) recommended that, for all but sacrocolpopexy for vaginal vault prolapse repair [70] , 'special arrangements for clinical governance, consent and audit or research' should be used [71] [72] [73] [74] . The implications are that the 'clinical governance leads in their Trusts should be informed, and patients need to be explicitly counselled about the uncertainty regarding safety and efficacy. Clear written information must be provided.' NICE also recommend that clinicians should enter details about all patients undergoing the procedures on the British Society for Urogynaecology Database so that a UK-wide audit of current practice can be carried out.
In addition, rigorous RCTs, with adequate power to detect clinically meaningful differences and long-term outcomes, are needed to determine the comparative efficacy of mesh techniques and their optimal place in the treatment of middle compartment prolapse. They should use validated patient-reported outcome measures, primarily to compare the failure rates and safety profiles, between mesh and nomesh techniques, between different types of mesh techniques and between different types of mesh. properties of mesh produced by the manufacturers and published studies relating to mesh; and Paul Moran for providing additional information for a study identified from the National Research Register database.
Contribution to authorship XJ and CG wrote this paper, and all authors contributed to its content. XJ screened the search results, contacted manufacturers, assessed studies for inclusion, undertook data abstraction and quality assessment, conducted data analysis and drafted the Interventional Procedures review on which this paper is based. CG drafted the scope, provided advice on study inclusion, determined outcome categories, drafted the background and methods sections of the review and commented on drafts of the review. GM commented on the scope of the review, drafted letters for contacting mesh manufacturers for additional information, supervised the conduct of the review and commented on drafts of the review. DJ provided advice on statistical analysis, checked the analysis results and commented on drafts of the review. CF developed and ran the literature search strategies, obtained papers, formatted the references and drafted sections concerning search strategies and search results. CB provided specialist advice on classification of mesh techniques and commented on drafts of the review. JB supervised the conduct of the review and commented on drafts of the review. Conflicts of interest None. 
